Family Legacy, Inc. Abb Vie Inc. Transaction History

Family Legacy, Inc.

$277 Million
Q1 2024

A detailed history of Family Legacy, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Family Legacy, Inc. holds 10,821 shares of ABBV stock, worth $1.81 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

10,821

Previous 11,126 2.74%

Holding current value

$1.81 Million

Previous $1.72 Million 14.27%

% of portfolio

0.71%

Previous 0.66%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $48,745 - $55,540	-305 Reduced 2.74%	10,821 $1.97 Million
Q4 2023 Jan 17, 2024	BUY	$137.6 - $154.97 $412 - $464	3 Added 0.03%	11,126 $1.72 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $8,950 - $10,361	-67 Reduced 0.6%	11,123 $1.66 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $3,710 - $4,617	-28 Reduced 0.25%	11,190 $1.51 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $39,767 - $45,798	275 Added 2.51%	11,218 $1.79 Million

Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $42,737 - $51,253	-309 Reduced 2.75%	10,943 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $17,984 - $20,626	134 Added 1.21%	11,252 $1.51 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $11,422 - $14,521	-83 Reduced 0.74%	11,118 $1.7 Million
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $18,741 - $23,252	142 Added 1.28%	11,201 $1.82 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $66,821 - $84,548	622 Added 5.96%	11,059 $1.52 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $9,150 - $10,387	86 Added 0.83%	10,437 $1.16 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $11,467 - $12,775	109 Added 1.06%	10,351 $1.22 Million
Q1 2021 Apr 09, 2021	BUY	$102.3 - $112.62 $23,426 - $25,789	229 Added 2.29%	10,242 $1.11 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $10,222 - $13,801	127 Added 1.28%	10,013 $1.07 Million
Q3 2020 Oct 09, 2020	BUY	$85.91 - $100.83 $70,703 - $82,983	823 Added 9.08%	9,886 $866,000
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $2,054 - $2,749	28 Added 0.31%	9,063 $890,000
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $5,160 - $7,823	-80 Reduced 0.88%	9,035 $688,000
Q4 2019 Jan 14, 2020	SELL	$72.13 - $90.25 $9,016 - $11,281	-125 Reduced 1.35%	9,115 $816,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $223,138 - $268,275	3,543 Added 62.19%	9,240 $758,000
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $8,935 - $11,421	136 Added 2.45%	5,697 $414,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $19,747 - $23,242	256 Added 4.83%	5,561 $467,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $26,546 - $32,739	341 Added 6.87%	5,305 $489,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $10,046 - $11,168	113 Added 2.33%	4,964 $470,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $86,637 - $102,511	965 Added 24.83%	4,851 $449,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $15,733 - $21,068	171 Added 4.6%	3,886 $368,000
Q4 2017 Feb 01, 2018	BUY	$89.56 - $98.21 $332,715 - $364,850	3,715	3,715 $359,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Legacy, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Legacy, Inc. with notifications on news.

Account

Family Legacy, Inc. Abb Vie Inc. Transaction History